Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/25–06/26 | 06/29 | 51,442 sh3 trades | $5.80avg. | $298,234.87 | −1.4% | |
Philippe MenuChief Medical Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/25 | 06/26 | 5,000 sh | $5.50 | $27,500 | −2.0% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/25 | 06/26 | 6,944 sh | $5.51 | $38,261.44 | −3.4% | |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/22 | 06/23 | 774 sh | $5.38 | $4,164.12 | −0.2% | |
Ross MukenPresident | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/22 | 06/23 | 422 sh | $5.38 | $2,270.36 | −0.1% |
Zhenyu XuChief Scientific Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/15 | 06/17 | 4,000 sh | $5.01 | $20,040 | −0.6% |
Philippe MenuChief Medical Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/12 | 06/15 | 5,000 sh | $4.95 | $24,750 | −2.0% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 06/10 | 06/11 | 8,500 sh | $5.24 | $44,540 | −0.2% | |
SOPHiA GeneticsSOPH | Open-market buy | 06/05 | 06/05 | 20,000 sh | $4.95 | $99,000 | +6.9% | |
Philippe MenuChief Medical Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/26 | 06/01 | 5,000 sh | $4.95 | $24,750 | −2.0% |
Ross MukenPresident | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 761 sh | $4.60 | $3,500.6 | −0.1% |
Zhenyu XuChief Scientific Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 608 sh | $4.60 | $2,796.8 | −0.1% |
Daan Van WellChief Legal Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 684 sh | $4.60 | $3,146.4 | −0.2% |
SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 4,486 sh | $4.60 | $20,635.6 | −0.1% | |
Manuela ValenteChief People Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 380 sh | $4.60 | $1,748 | −0.2% |
Philippe MenuChief Medical Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/19 | 05/20 | 608 sh | $4.61 | $2,802.88 | −0.2% |
Kevin PuylaertChief Sales Officer | SOPHiA GeneticsSOPH | Open-market sale | 05/19 | 05/20 | 33 sh | $4.54 | $149.82 | −0.0% |
Zhenyu XuChief Scientific Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/13 | 05/14 | 4,000 sh | $4.54 | $18,160 | −0.6% |
Kathy L. HibbsDirector | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/12 | 05/13 | 7,508 sh | $4.67 | $35,062.36 | −7.7% |
Philippe MenuChief Medical Officer | SOPHiA GeneticsSOPH | Open-market sale10b5-1 plan | 05/12 | 05/13 | 5,000 sh | $4.67 | $23,350 | −1.9% |
